Bifidobacterium in anticancer immunochemotherapy: friend or foe?

The gut microbiome has received a crescendo of attention in recent years due to myriad influences on human pathophysiology, including cancer. Anticancer therapy research is constantly looking for new hints to improve response to therapy while reducing the risk of relapse. In this scenario, Bifidobac...

Descripción completa

Detalles Bibliográficos
Autores principales: Procaccianti, Giorgia, Roggiani, Sara, Conti, Gabriele, Brigidi, Patrizia, Turroni, Silvia, D’Amico, Federica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OAE Publishing Inc. 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688788/
https://www.ncbi.nlm.nih.gov/pubmed/38046824
http://dx.doi.org/10.20517/mrr.2023.23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688788/
https://www.ncbi.nlm.nih.gov/pubmed/38046824
http://dx.doi.org/10.20517/mrr.2023.23

Ejemplares similares